Samsung Bioepis CH GmbH - Byooviz 10 mg / ml, Injektionslösung in Fertigspritze Swissmedic Registration 70708 Sequence 01 Product name Byooviz 10 mg / ml Description Injektionslösung in Fertigspritze ATC-Classification S01LA04 ATC-Description Ranibizumab Introduction of Sequence 12.05.2026
Composition ranibizumabum 1.65 mg, trehalosum dihydricum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. Packungsbestandteile Galenic Form Injection solution in prefilled syringe Excipiens Active Agent Dose Ranibizumab 1.65 mg/ml
Inactive agents Histidin Hydrochloride Monohydrate Histidine Polysorbatum 20 Trehalosum Dihydricum
Package number Package Size EFP CP Category SL Out of trade (MedRef) 001 B Yes
